| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |